Literature DB >> 31342117

Border Medicine: The Pediatric Cardiology Perspective.

Ashutosh Agrawal1, Sethuraman Swaminathan2, Suvarna L Guvvala1, Sudheer R Gorla3.   

Abstract

Pediatric cardiology and cardiovascular surgery have witnessed significant advancements over the last two decades. In spite of this progress, congenital heart disease (CHD) still remains as one of the major causes of death in infants and young children in the United States. Many patient-related and patient-independent factors influence the outcomes in patients with CHD, one of which is the geographical location. In the US-Mexico border, management and outcomes of patients with CHD are further complicated by additional problems stemming from complex interplay between two different health systems, and socioeconomic disparities. In this article, the authors evaluate the various interplaying factors and describe the difficulties facing the practicing pediatric cardiologists in a US-Mexico border city.

Entities:  

Keywords:  Congenital heart disease; Pediatric cardiology; US–Mexico border

Mesh:

Year:  2019        PMID: 31342117     DOI: 10.1007/s00246-019-02171-7

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  10 in total

Review 1.  The changing epidemiology of congenital heart disease.

Authors:  Teun van der Bom; A Carla Zomer; Aeilko H Zwinderman; Folkert J Meijboom; Berto J Bouma; Barbara J M Mulder
Journal:  Nat Rev Cardiol       Date:  2010-11-02       Impact factor: 32.419

2.  Age at referral and mortality from critical congenital heart disease.

Authors:  David E Fixler; Ping Xu; Wendy N Nembhard; Mary K Ethen; Mark A Canfield
Journal:  Pediatrics       Date:  2014-07       Impact factor: 7.124

3.  Adverse events during interhospital transport: physiologic deterioration associated with pretransport severity of illness.

Authors:  R K Kanter; J M Tompkins
Journal:  Pediatrics       Date:  1989-07       Impact factor: 7.124

4.  Emerging trends in the prenatal diagnosis of complex CHD and its influence on infant mortality in this cohort.

Authors:  Sudheer R Gorla; Abhishek Chakraborty; Ashish Garg; Rubee A Gugol; Richard E Kardon; Sethuraman Swaminathan
Journal:  Cardiol Young       Date:  2018-12-26       Impact factor: 1.093

5.  Impact of prenatal diagnosis of complex congenital heart disease on neonatal and infant morbidity and mortality.

Authors:  Abhishek Chakraborty; Sudheer R Gorla; Sethuraman Swaminathan
Journal:  Prenat Diagn       Date:  2018-09-27       Impact factor: 3.050

6.  The meaning of cost for families of children with congenital heart disease.

Authors:  Jean Anne Connor; Nancy E Kline; Sandra Mott; Sion Kim Harris; Kathy J Jenkins
Journal:  J Pediatr Health Care       Date:  2010-01-06       Impact factor: 1.812

7.  Pulmonary Vein Stenosis: Outcomes in Children With Congenital Heart Disease and Prematurity.

Authors:  Michael P DiLorenzo; Ashley Santo; Jonathan J Rome; Huayan Zhang; Jennifer A Faerber; Laura Mercer-Rosa; Rachel K Hopper
Journal:  Semin Thorac Cardiovasc Surg       Date:  2018-09-29

8.  Prostaglandin Availability and Association with Outcomes for Infants with Congenital Heart Disease.

Authors:  Brady S Moffett; Joshua M Garrison; Aimee Hang; Shaine A Morris; Rocky Tsang; Kimberly Dinh; Pamela Griffiths; Ronald Bronicki; Paul A Checchia
Journal:  Pediatr Cardiol       Date:  2015-10-24       Impact factor: 1.655

9.  Effects of Gestational Age on Early Survivability in Neonates With Hypoplastic Left Heart Syndrome.

Authors:  Joseph T Mechak; Erika M Edwards; Kate A Morrow; Jonathan R Swanson; Jeffrey Vergales
Journal:  Am J Cardiol       Date:  2018-07-21       Impact factor: 2.778

10.  Socioeconomic Mediators of Racial and Ethnic Disparities in Congenital Heart Disease Outcomes: A Population-Based Study in California.

Authors:  Shabnam Peyvandi; Rebecca J Baer; Anita J Moon-Grady; Scott P Oltman; Christina D Chambers; Mary E Norton; Satish Rajagopal; Kelli K Ryckman; Laura L Jelliffe-Pawlowski; Martina A Steurer
Journal:  J Am Heart Assoc       Date:  2018-10-16       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.